Development of an aptamer-based affinity purification method for vascular endothelial growth factor

Area of Science:

• Biochemistry
• Molecular Biology
• Biotechnology

Background:

• Aptamers are chemically synthesized oligonucleotides with high affinity and specificity for target molecules.
• They present advantages over antibodies for protein purification, including large-scale production under GMP conditions.
• This makes aptamers suitable for therapeutic protein production.

Purpose of the Study:

• To establish a small-scale purification platform for human Vascular Endothelial Growth Factor (VEGF) using an aptamer as the affinity ligand.
• To demonstrate the efficacy and specificity of aptamer-based affinity purification.

Main Methods:

• Covalent immobilization of a VEGF-specific aptamer onto magnetic beads to create an affinity matrix.
• Optimization of target binding through the use of spacer molecules and varying aptamer density.
• Demonstration of salt-induced target elution and purification of VEGF from a complex protein mixture.

Main Results:

• A functional and active aptamer-based affinity matrix was successfully created.
• Binding and purification conditions were optimized for efficient VEGF capture.
• Specific purification of VEGF from a complex protein mixture was achieved, validating the aptamer's specificity.

Conclusions:

• Aptamer-based affinity purification is a viable and specific method for isolating target proteins like VEGF.
• The developed platform demonstrates the potential of aptamers in protein purification for research and therapeutic applications.
• Aptamers offer a scalable and controlled alternative to traditional affinity ligands.